SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-19-001142
Filing Date
2019-05-10
Accepted
2019-05-10 08:00:34
Documents
8
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K essa6k.htm 6-K 10343
2 NEWS RELEASE DATED MAY 10, 2019 ex991.htm EX-99.1 41904
3 99.2 CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDE ex992.htm EX-99.2 392721
4 FORM 51-102F1 MANAGEMENT DISCUSSION AND ANALYSIS FOR THE SIX MONTHS ENDED MARCH ex993.htm EX-99.3 300796
5 FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS CEO ex994.htm EX-99.4 6859
6 FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS CFO ex995.htm EX-99.5 6835
7 GRAPHIC ex992_001.jpg GRAPHIC 13262
8 GRAPHIC ex993_footer.jpg GRAPHIC 1274
  Complete submission text file 0001279569-19-001142.txt   780772
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-37410 | Film No.: 19812900
SIC: 2834 Pharmaceutical Preparations